首页> 外文期刊>Hong Kong Journal of Paediatrics >Introducing the Guideline on Management of Urinary Tract Infection in Children by the National Institute for Health and Clinical Excellence (NICE Guideline)
【24h】

Introducing the Guideline on Management of Urinary Tract Infection in Children by the National Institute for Health and Clinical Excellence (NICE Guideline)

机译:国立卫生与临床医学研究所引入儿童尿路感染管理指南(NICE指南)

获取原文
           

摘要

The concept and management of urinary tract infection in children has been evolving over the past decades. While previous guidelines advocated universal imaging and antibiotic prophylaxis for young children with first time urinary tract infection (UTI), the recent guideline issued by the National Institute for Health and Clinical Excellence in the United Kingdom in August 2007 recommended a more selective strategy. This article presents a summary of the NICE Guideline with comments and recommendations by the authors. The Guideline was stringently developed and has incorporated recent scientific findings. Compared to previous guidelines, the major changes include the following: Firstly, it presents a complex algorithm for the diagnosis of UTI by rapid bedside tests. Diagnosis does not require urine culture in children above 3 years old who show positive dipstix results. Secondly it adopts a selective imaging strategy after first UTI. Ultrasound was recommended for infants below 6 months, or children of any age with atypical or recurrent UTI. Dimercapto-succinic acid scan was recommended for infants below 3 years with atypical or recurrent UTI, and those above 3 years with recurrent UTI. Micturiting cystourethrogram was recommended only for infants below 6 months with atypical or recurrent UTI or with abnormal ultrasound, and for infants above 6 months with atypical or recurrent UTI AND a family history of vesicoureteral reflux (VUR), poor urine stream, non-E.coli infection, or dilated renal pelves. Thirdly, antibiotic prophylaxis or surgery was not recommended routinely for VUR treatment. The authors discuss several concerns and suggest the following modifications for local practice: that a pre-treatment urine culture is useful in treatment by identifying the pathogen and its antibiotic sensitivity; that an ultrasound scan is reasonable, if a patient has not had a reliable antenatal or postnatal ultrasound, to exclude obstructive uropathies. For imaging strategy after a first UTI, the NICE Guideline is a reasonable approach if parents accept the small possibility of missing severe VUR for which the optimal treatment is still undecided. Until further evidence is available, a prudent option is to continue full imaging for infants below 12 months old and recommend antibiotics prophylaxis for Grade IV-V VUR. Further research is needed to better define the best treatment for severe VUR and to devise an investigation strategy that can identify those patients who may benefit from early detection of VUR and its treatment, and at the same time avoid over-investigating and over-treating the remaining patients.
机译:在过去的几十年中,儿童尿路感染的概念和管理一直在发展。先前的指南主张对初次患有尿路感染(UTI)的幼儿进行通用显像和抗生素预防,但英国国家卫生与临床卓越研究所(National Institute for Health and Clinical Excellence)于2007年8月发布的最新指南建议采取更具选择性的策略。本文介绍了NICE指南的摘要以及作者的评论和建议。该指南经过严格制定,并纳入了最新的科学发现。与以前的指南相比,主要变化包括:首先,它提出了一种通过床旁快速诊断来诊断UTI的复杂算法。诊断无需对3岁以上的儿童进行双尿结果阳性的尿培养。其次,在首次UTI之后采用了选择性成像策略。对于6个月以下的婴儿或非典型或复发性UTI的任何年龄的儿童,建议使用超声检查。建议对非典型或复发性UTI的3岁以下婴儿和复发性UTI的3岁以上的婴儿进行二巯基琥珀酸扫描。仅对非典型或复发性UTI或超声检查异常的6个月以下婴儿,非典型或复发性UTI且有膀胱输尿管反流(VUR)家族史,尿流不畅,非E的6个月以上的婴儿,建议行膀胱尿道造影检查。大肠杆菌感染或肾盂扩张。第三,不建议对VUR治疗常规进行抗生素预防或手术。作者讨论了几个问题,并建议对当地实践进行以下修改:预处理尿培养可通过识别病原体及其对抗生素的敏感性来进行治疗;如果患者没有可靠的产前或产后超声检查,超声扫描是合理的,以排除阻塞性尿路病。对于首次接受UTI后的影像学策略,如果父母接受遗失严重VUR的可能性很小,而仍未确定最佳治疗方案,那么NICE指南是一种合理的方法。在没有进一步的证据可用之前,谨慎的选择是继续对12个月以下的婴儿进行全面成像,并建议对IV-V级VUR进行抗生素预防。需要进行进一步的研究以更好地确定重症VUR的最佳治疗方法,并设计出一项调查策略,以识别可能从VUR及其治疗的早期发现中受益的患者,同时避免过度研究和过度治疗VUR。其余的病人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号